AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 NOV 21 - (NewsRx.com & NewsRx.net) -- Advances in the study of viral genomes has laid the foundation for rapid progress in the development of new antiviral vaccines and drugs.
"The 1950s were the golden age of antibiotics to treat bacterial infections," William A. Haseltine, PhD, said. "We are now in the early years of the golden age of antiviral drugs. The 1990s witnessed the discovery of a wide array of new antiviral drugs for the treatment of diseases such as hepatitis B, herpes and AIDS. The next decade will witness the discovery of many more new antiviral drugs and vaccines for diseases ranging from the common cold to more serious life-threatening diseases such as Ebola and hepatitis C. These impressive advances have been made possible by scientific progress made two decades ago in the 1980s in the field of viral genomics."
Haseltine is the author of a article which was selected for the cover of the November 2001 issue of the journal Scientific American.
Haseltine's article points out that until the early 1980s, medicine had few remedies to offer for viral diseases "beyond chicken soup and a cluster of vaccines."
Today, thanks in large part to genomic research, hundreds of antiviral drugs are in development, and dozens are being tested in volunteers against a wide variety of viruses, from cold viruses to herpes viruses, and from influenza viruses to the human immunodeficiency virus. Vaccines developed with the help of genomics are in development for a number of important viral diseases, among them HIV, dengue fever, genital herpes ...
Source: HighBeam Research, Article Describes New "Golden Age" Of Antiviral Drugs And...